Privia Health Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Privia Health Group, Inc. (PRVA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Privia Health Group, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 93.79K shares, a 97.50% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-07 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 0.00 shares 10-Q · filed 2024-11-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-27 | 0.00 shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-03 | 0.00 shares 10-Q · filed 2023-11-03 | 0.00 shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 0.00 shares 10-Q · filed 2023-08-03 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-27 | 0.00 shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-04 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-27 | 64.88K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 64.88K shares derived: sum of 3 quarters · filed 2025-02-27 | 93.79K shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 64.88K shares derived: sum of 2 quarters · filed 2022-11-10 | 93.79K shares 10-Q · filed 2022-11-10 | 116.39K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 64.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 93.79K shares 10-Q · filed 2022-08-11 | 116.39K shares derived: sum of 3 quarters · filed 2024-02-27 | 163.89K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 28.91K shares 10-Q · filed 2022-05-12 | 51.51K shares derived: sum of 2 quarters · filed 2024-02-27 | 99.01K shares derived: sum of 3 quarters · filed 2024-02-27 | 3.78M shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 22.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 70.10K shares derived: sum of 2 quarters · filed 2024-02-27 | 3.75M shares derived: sum of 3 quarters · filed 2024-02-27 | 3.75M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 47.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 3.73M shares derived: sum of 2 quarters · filed 2021-11-08 | 3.73M shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 3.68M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 3.68M shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |